Skip to main content
HIMS
NYSE Life Sciences

Hims Cuts 2026 Outlook After Q3 Revenue Miss, Pivots to Branded Weight-Loss Drugs

Tom Rudovsky · Reported by Wiseek News
More coverage: Household Product Stocks · Consumer
Sentiment info
Negative
Importance info
8
Price
$22.16
Mkt Cap
$5.352B
52W Low
$13.74
52W High
$42.7
52W Position info
61% above low
Off High info
48% below high
Rel. Volume info
4.5× avg
Market data snapshot near publication time

HIMS sits 61% above its 52-week low of $13.74 on elevated volume (4.5× avg).

Summary

Hims posted Q3 revenue of $890.4 million, up 49% year over year but short of estimates, and a $33 million net loss — then cut its 2026 revenue and adjusted EBITDA forecasts. The guidance cut is the part that matters: growth is decelerating faster than the top line suggests, and the margin picture is already ugly after gross margin fell to 57%. Management is repositioning the weight-loss business around FDA-approved branded drugs, adding Eli Lilly's Zepbound and Foundayo after agreeing to offer Novo Nordisk's Ozempic and Wegovy — a retreat from the compounded GLP-1 model that drew FDA and Visa scrutiny earlier this year. The Peptides+ program launches by late November, though the company expects peptide revenue to be immaterial in Q4. Separately, Dr. Andrew Huberman joined the board with a $3.5 million annual advisory agreement disclosed in an 8-K.

At the time of this announcement, HIMS was trading at $22.16 on NYSE in the Life Sciences sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $13.74 to $42.70. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

HIMS - Latest Insights

HIMS
Nov 11, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $19.00
Real-time Price: $20.28 info
Change: +$1.28 (+7%) info
Market Cap: $4.855B info
HIMS
Nov 10, 2026, 1:54 PM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $18.85
Real-time Price: $20.28 info
Change: +$1.44 (+8%) info
Market Cap: $4.855B info
HIMS
Nov 09, 2026, 5:52 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.33
Real-time Price: $20.28 info
Change: -$2.05 (-9%) info
Market Cap: $4.855B info
HIMS
Nov 09, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.39
Real-time Price: $20.28 info
Change: -$3.11 (-13%) info
Market Cap: $4.855B info
HIMS
Nov 09, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.18
Real-time Price: $20.28 info
Change: -$1.90 (-9%) info
Market Cap: $4.855B info